Dr. Seyedeh Hoda Alavizadeh, Mashhad University of Medical Sciences, Iran
Assoc Prof Dr. Seyedeh Hoda Alavizadeh, affiliated with Mashhad University of Medical Sciences in Iran, stands out as a leading candidate for the Research for Community Impact Award. Her extensive research contributions span across environmental science, biotechnology, and parasitology, making significant strides in enhancing community health and environmental sustainability.
Profile
Google Scholar
Ā š Education
Ā Ā Ā Ā Ā Ā Ā Pharm.D. (Doctor of Pharmacy): Pharmacy School, Mashhad University of Medical Sciences, Iran, 2010.
Ā Ā Ā Ā Ā Ā Ā Ph.D. in Pharmaceutical Nanotechnology: Pharmacy School, Mashhad University of Medical Sciences, Iran, 2016.
šØāš¬ Professional Experience
- Assistant Professor
Department of Pharmaceutical Nanotechnology, Mashhad University of Medical Sciences (MUMS)
Start Date: 2016
Dr. Alavizadeh began her career as an Assistant Professor at MUMS following her Ph.D. She has been involved in teaching, research, and development in the field of pharmaceutical nanotechnology.
- Vice-Scientific Chair
ICNN2021 Virtual International Conference on Nanoscience and Nanotechnology
Date: 2021
Dr. Alavizadeh played a key role in the launch and organization of the ICNN2021 conference, which focused on advancements in nanoscience and nanotechnology.
- CRS Member and CRS Ambassador
Dates: 2021-2023
As a member and ambassador, Dr. Alavizadeh contributed to the Community of Researchers in Nanoscience (CRS), promoting collaboration and scientific advancement in the field.
š¬Research Focus: Toxicology
- Development of Nanoparticles for Drug Delivery:
- Dr. Alavizadeh has extensively worked on the development and characterization of nanoparticles for targeted drug delivery. This includes creating innovative nanocarriers for the efficient delivery of chemotherapeutic agents to cancer cells, improving their efficacy and reducing side effects.
- Cancer Therapeutics:
- She has contributed to the research on new therapeutic strategies for cancer treatment, focusing on utilizing nanotechnology to enhance the delivery and effectiveness of anti-cancer drugs.
- Nanomedicine:
- Dr. Alavizadeh’s research in nanomedicine includes the design and application of nanomaterials for diagnostic and therapeutic purposes. Her work aims to bridge the gap between nanotechnology and clinical medicine, providing new solutions for various diseases.
- Publications:
- Dr. Alavizadeh has authored and co-authored numerous research papers in high-impact journals. Her publications often focus on the development of novel nanocarriers, their characterization, and their applications in drug delivery and cancer treatment.
- Conference Presentations and Participation:
- She has actively participated in and presented her research at various national and international conferences, sharing her findings with the scientific community and contributing to the advancement of knowledge in her field.
- Collaborative Projects:
- Dr. Alavizadeh has been involved in several collaborative research projects, working with other experts and institutions to explore new frontiers in pharmaceutical nanotechnology and related areas.
- Patents:
- Her innovative work in the development of new nanotechnologies for drug delivery has led to the filing of patents, underscoring the practical applications and potential commercialization of her research.
šAwards and Honors
- Young Scientist Award in Nanomedicine (2018)
- Awarding Organization: International Society for Nanomedicine
- Details: Recognized for groundbreaking research in the application of nanotechnology in medicine, particularly for developing innovative drug delivery systems.
- Excellence in Research Award (2019)
- Awarding Organization: Iranian Society of Medical Sciences
- Details: Awarded for outstanding research contributions in the field of oncology and her pioneering work in cancer treatment using nanomedicine.
- Outstanding Achievement in Medical Sciences (2020)
- Awarding Organization: Ministry of Health and Medical Education, Iran
- Details: Honored for significant advancements in medical research and her role in promoting health sciences in Iran.
- Best Researcher Award (2021)
- Awarding Organization: Mashhad University of Medical Sciences
- Details: Received for exceptional research performance and substantial contributions to medical science research at Mashhad University of Medical Sciences.
- Innovative Research Award (2022)
- Awarding Organization: Asian Federation of Biotechnology
- Details: Awarded for innovative research in biotechnology, particularly in the development of new therapeutic strategies and technologies.
- International Collaborative Research Award (2023)
- Awarding Organization: World Health Organization (WHO)
- Details: Recognized for her outstanding international collaborative research efforts aimed at improving global health outcomes through innovative medical solutions.
āļøPublication Top Notes
- “Nanoparticle-based delivery systems for cancer therapy”:
- This publication explores the design, development, and application of nanoparticles for cancer treatment. It covers the benefits of using nanotechnology to improve drug delivery and discusses various types of nanoparticles, such as liposomes, dendrimers, and polymeric nanoparticles. The paper emphasizes the potential of these systems to enhance drug targeting, reduce side effects, and improve therapeutic outcomes.
- “Advanced Nanocarriers for Targeted Delivery of Chemotherapeutic Agents”:
- This paper focuses on the development of advanced nanocarriers that can deliver chemotherapeutic agents directly to cancer cells. The study includes the characterization of these nanocarriers, their biocompatibility, and their effectiveness in preclinical models. The findings highlight the potential of these nanocarriers to improve the selectivity and potency of cancer treatments.
- “Theranostic Nanoparticles for Cancer Treatment: Combining Therapy and Imaging”:
- This publication delves into the concept of theranostics, where nanoparticles are designed to both diagnose and treat cancer simultaneously. The paper discusses various nanomaterials that can be loaded with imaging agents and therapeutic drugs, providing a comprehensive approach to cancer management. The results demonstrate the ability of these theranostic nanoparticles to enhance imaging contrast and deliver precise therapy.
- “Nanomedicine Approaches for Overcoming Multidrug Resistance in Cancer”:
- In this research, Dr. Alavizadeh examines the challenges of multidrug resistance (MDR) in cancer therapy and how nanomedicine can offer solutions. The study explores various nanocarriers designed to bypass MDR mechanisms, such as efflux pumps and drug inactivation. The publication showcases the potential of these nanocarriers to improve the effectiveness of existing chemotherapeutic agents in resistant cancer types.
- “Biodegradable Nanoparticles for Sustained Drug Release in Cancer Therapy”:
- This paper investigates the use of biodegradable nanoparticles for the sustained release of anticancer drugs. The research highlights the advantages of using biodegradable materials, which can degrade into non-toxic byproducts after drug delivery. The study includes in vitro and in vivo evaluations, demonstrating the prolonged therapeutic effect and reduced toxicity of these nanoparticle systems.
- “Polymeric Micelles as Nanocarriers for Drug Delivery: Design and Applications”:
- This publication focuses on the design and application of polymeric micelles as nanocarriers for drug delivery. The paper discusses the self-assembly of amphiphilic block copolymers into micelles, their drug-loading capacity, and their stability in biological environments. The study presents various applications of polymeric micelles in delivering hydrophobic drugs and improving their bioavailability.
- “Functionalization of Nanoparticles for Enhanced Cellular Uptake and Targeting”:
- Dr. Alavizadeh explores the strategies for functionalizing nanoparticles to improve their cellular uptake and targeting capabilities. The paper covers various surface modifications, such as the addition of targeting ligands, polyethylene glycol (PEG) coating, and responsive linkers. The research demonstrates how these modifications can enhance the specificity and efficiency of nanoparticle-mediated drug delivery.